2025-04-30 - Analysis Report
## Rocket Lab USA Inc (RKLB) Stock Analysis Report

**0. Key Figures Summary:**

* **Cumulative Return (RKLB):** 178.89%
* **Cumulative Return (VOO):** 20.07%
* **Return Difference (RKLB vs VOO):** 158.82%
* **Current Closing Price:** $22.40
* **Market Risk Indicator (MRI):** 0.379 (Medium Risk)


**1. Performance Comparison & Alpha/Beta Analysis:**

Rocket Lab USA Inc. (RKLB) is a space launch and satellite manufacturing company.  RKLB significantly outperformed the S&P 500 (VOO) over the analyzed period. The cumulative return difference of 158.82% places RKLB at the 89.5th percentile of its historical performance range relative to VOO.  However, the Alpha values consistently show negative performance relative to the market, suggesting underperformance adjusted for market risk.  The high Beta values indicate significant volatility and sensitivity to market movements.  The substantial increase in Beta from 2020-2022 to 2023-2025 suggests increased market sensitivity, possibly linked to company growth and market fluctuations.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) | Notes |
|------------|------|------|-------|------|-------|-------|
| 2020-2022  | -39.0% | 70.8% | -37.0% | 1.7 |       | Significant losses, high volatility |
| 2021-2023  | 0.0% | 71.5% | -19.0% | 2.5 |       | Stagnant performance, very high volatility |
| 2022-2024  | 189.0% | 74.7% | -0.0 | 11.6 |       | Strong growth, extremely high volatility |
| 2023-2025  | 198.0% | 74.7% | -0.1 | 10.2 |       | Continued strong growth, high volatility |


**2. Recent Price Movements:**

* **Closing Price:** $22.40
* **Previous Close:** $22.67
* **5-Day Moving Average:** $21.92
* **20-Day Moving Average:** $19.68
* **60-Day Moving Average:** $21.29

The price shows a recent slight downward trend, although it's above both the 5-day and 20-day moving averages, suggesting potential short-term support.  The price is close to its 60-day moving average, indicating a more neutral medium-term trend. The significant negative change of -1.19 from the previous close suggests a recent minor pullback.

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.379 (Medium Risk)
* **RSI:** 69.30 (Approaching overbought territory)
* **PPO:** 2.41 (Positive, suggesting bullish momentum)
* **Delta_Previous_Relative_Divergence:** +15.3 (Short-term upward trend)
* **Expected Return (2+ years):** -4.8% (This suggests that while the stock has significantly outperformed in the past,  current market expectations suggest a potential underperformance against the S&P 500 over the next 2+ years.  This is contingent on the current market outlook and could change.)


**4. Recent Earnings Analysis:**

The company shows consistent negative EPS, indicating ongoing losses. While revenue is growing, the negative EPS and the need for continued investment suggest the company is still in a growth phase.  Further analysis of profitability relative to investment is needed to fully assess the sustainability of this growth.

| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2024-11-12 | -0.1  | $0.10 B       |
| 2024-08-08 | -0.08 | $0.11 B       |
| 2024-05-06 | -0.09 | $0.09 B       |
| 2023-11-08 | -0.08 | $0.07 B       |
| 2024-11-12 | -0.08 | $0.07 B       | *(Duplicate entry, potential data error)*


**5. Financial Information:**

Revenue is growing consistently, indicating increasing market traction.  Profit margins are healthy, although the negative ROE indicates that the company is not yet generating returns on equity, likely due to significant investments in growth.  The high equity suggests a healthy balance sheet, but the negative ROE should be closely monitored.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.13B | 27.81%       |
| 2024-09-30 | $0.10B | 26.71%       |
| 2024-06-30 | $0.11B | 25.56%       |
| 2024-03-31 | $0.09B | 26.06%       |
| 2023-12-31 | $0.06B | 25.82%       |

**Capital and Profitability:**

| Quarter | Equity | ROE       |
|---------|---------|-----------|
| 2024-12-31 | $0.38B | -13.69%   |
| 2024-09-30 | $0.42B | -12.37%   |
| 2024-06-30 | $0.46B | -9.15%    |
| 2024-03-31 | $0.48B | -9.24%    |
| 2023-12-31 | $0.55B | -9.11%    |


**6. Overall Analysis:**

RKLB demonstrates strong past performance compared to the S&P 500, but this is accompanied by significant volatility and negative Alpha.  While revenue is growing and profit margins are healthy, the negative ROE and consistent negative EPS highlight the company's ongoing investment in growth.  The high Beta indicates significant market risk.  Investors should carefully consider the high volatility and the company's stage of development before investing.  Further due diligence, including a thorough examination of the company's long-term strategy and competitive landscape, is recommended before making any investment decisions.  The negative projected long-term return relative to the S&P 500 warrants caution.  The high valuation is another factor to consider.  Potential investors need to weigh the high growth potential against the risks involved.
